Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

LANNETT COMPANY, INC. (LCI)
Mes dernières consult.
Most popular
Report
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
Kristin A. Arnold, PhD-2017Vice President-Research & Development
David A. Drabik482010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III562015Independent Director
Patrick G. LePore, MBA622017Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,893,471 28,107,561 74.2% 609,154 1.6% 74.2%
Shareholders
NameEquities%
Telemus Capital LLC 6,019,820 16.1%
Jeffrey Farber 4,534,186 12.2%
BlackRock Fund Advisors 3,632,800 9.74%
David J. Farber 3,627,848 9.73%
Snow Capital Management LP 3,152,240 8.45%
The Vanguard Group, Inc. 2,868,320 7.69%
LSV Asset Management 1,681,535 4.51%
Deerfield Management Company LP 1,523,957 4.09%
Morgan Stanley & Co. LLC 1,146,407 3.07%
SSgA Funds Management, Inc. 1,077,622 2.89%
Company contact information
Lannett Co., Inc.
9000 State Road
Philadelphia, PA 19136

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.902
JOHNSON & JOHNSON23.60%382 202
NOVARTIS13.50%226 404
PFIZER11.58%216 886
ROCHE HOLDING LTD.5.55%207 116
MERCK AND COMPANY7.88%174 223
AMGEN27.41%133 501
SANOFI8.99%124 704
BAYER19.94%114 930
BRISTOL-MYERS SQUIBB COMPANY10.66%105 644
NOVO NORDISK A/S25.13%99 069
GLAXOSMITHKLINE-1.66%98 802
ABBOTT LABORATORIES45.20%97 853
ELI LILLY AND COMPANY16.56%96 039
CELGENE CORPORATION18.51%94 923
ASTRAZENECA16.62%85 977
ALLERGAN PLC-10.89%62 943
TAKEDA PHARMACEUTICAL CO LTD30.84%44 061
SHIRE-21.49%43 958
ASTELLAS PHARMA INC-6.24%27 777
JIANGSU HENGRUI MEDICINE CO LTD39.85%27 656
Connections : Lannett Company, Inc.
Kremers Urban Pharmaceuticals, Inc.
Lautus Pharmaceuticals LLC
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
The American Institute of Certified Public Accountants
AgeneBio, Inc.
Cranbrook & Co. Llc
Endo Generics Holdings, Inc.
National Response Corp.
Tyme, Inc.
Generic Pharmaceutical Co.
Villanova University
© 2017 People , Fundamentals and Ownership